Deka Bank Deutsche Girozentrale Fate Therapeutics Inc Transaction History

Deka Bank Deutsche Girozentrale

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	SELL	$4.24 - $11.12 $42,400 - $111,199	-10,000 Reduced 25.0%	30,000 $158,000
Q3 2022 Nov 02, 2022	BUY	$21.04 - $36.06 $243,012 - $416,493	11,550 Added 40.6%	40,000 $887,000
Q1 2022 Apr 28, 2022	BUY	$29.67 - $60.28 $77,142 - $156,728	2,600 Added 10.06%	28,450 $1.13 Million
Q4 2021 Feb 02, 2022	BUY	$47.84 - $64.34 $33,488 - $45,038	700 Added 2.78%	25,850 $1.53 Million
Q3 2021 Oct 22, 2021	SELL	$59.27 - $95.73 $1.19 Million - $1.91 Million	-20,000 Reduced 44.3%	25,150 $1.5 Million
Q2 2021 Aug 05, 2021	BUY	$67.25 - $92.52 $1.01 Million - $1.39 Million	15,000 Added 49.75%	45,150 $3.99 Million
Q4 2020 Mar 12, 2021	BUY	$38.09 - $100.95 $228,540 - $605,700	6,000 Added 24.84%	30,150 $2.82 Million
Q3 2020 Oct 29, 2020	BUY	$30.41 - $40.5 $734,401 - $978,075	24,150 New	24,150 $940,000
Q4 2019 Feb 04, 2020	SELL	$13.39 - $20.73 $334,750 - $518,250	-25,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$15.47 - $22.5 $386,750 - $562,500	-25,000 Reduced 50.0%	25,000 $387,000
Q2 2019 Aug 01, 2019	BUY	$15.61 - $20.44 $780,500 - $1.02 Million	50,000 New	50,000 $1.02 Million
Q1 2019 May 10, 2019	SELL	$13.15 - $18.71 $328,750 - $467,750	-25,000 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$11.48 - $16.98 $287,000 - $424,500	25,000 New	25,000 $293,000

177

113M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $126M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.